StudyFinder

Efficacy and Safety of Benralizumab vs Mepolizumab in Treatment of EGPA (MANDARA)

Status: OPEN TO ACCRUAL

I'm interested

Age:

Healthy Volunteers:

Interventions:

drug: Mepolizumab, drug: Benralizumab

Conditions:

Diseases of Circulatory System (390-459)

Contact(s): ctrrecruit@vcu.edu

Principal Investigator: Ward, Brant

Phase: III

IRB Number: HM20018295

System ID: NCT04157348

Back